ABBVIE INC. vs. Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
ABBV
ABBVIE INC.
$291.31 +1.07%
VS KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares
$96.12 +3.03%
ABBVIE INC. and Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | KNSA | |
|---|---|---|
| Market Cap | $514.92 billion | $7.33 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | KNSA | |
|---|---|---|
| Dividend Yield | 2.50% | — |
ABBV and KNSA split the dividend factors evenly.
Risk & Sentiment
| ABBV | KNSA | |
|---|---|---|
| Short Interest | 0.85% | 0.02% |
KNSA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, KNSA overview, KNSA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.